DEC-RVRK-CMK TFA

DEC-RVRK-CMK TFA is a chloromethylketone inhibitor targeting the Kex2 protease, a calcium-dependent subtilisin-like proprotein convertase, with a Ki of 8.45 μM. Its P1 lysine selectivity influences binding affinity, making it a useful tool for studying serine protease mechanisms in vitro within yeast and mammalian protease research.